Sedation in the Intensive Care Unit

Sponsor
University Hospital, Geneva (Other)
Overall Status
Unknown status
CT.gov ID
NCT00221520
Collaborator
Swiss National Science Foundation (Other)
126
1
47
2.7

Study Details

Study Description

Brief Summary

High-risk critically ill patients often require mechanical ventilation either to primarily support the respiratory function or when the ventilation is insufficient to maintain adequate gas exchanges as a result of other organ impairment. In order to tolerate this aggressive mechanical support, enhance patient synchrony with the ventilator, and relieve pain and anxiety, analgesia and sedation are provided. It is suggested that an inappropriate use of sedation and analgesia may prolong the duration of mechanical ventilation and increase the risk of specific adverse outcomes such as ventilator associated pneumonia. Despite the widespread use of sedation, little information is available concerning the effect of varying the level of sedation on patients' subsequent mental health. We designed a randomized controlled trial to investigate the efficacy of sedation with the goal of maintaining the patient cooperative and interactive compared to the administration of sedation with the goal of maintaining the patient sedated. The first goal will be achieved by a discontinuous injection of a sedative, while the second goal will be achieved by a continuous infusion of the same sedative. In both groups pain relief will be provided in the same fashion with equal endpoints on a pain scoring scale. Our primary aim is to investigate whether differences in the occurrence of post-traumatic stress disorders (PTSD), anxiety, and depression are related to the choice of sedation-analgesia strategies. Secondary endpoints include the length of ICU stay, as indicated by the time to discharge from the ICU, the time to separation from mechanical ventilation, the rates of pulmonary and extra-pulmonary complications, and hospital length of stay. These endpoints will be compared between the two groups.

Condition or Disease Intervention/Treatment Phase
  • Drug: midazolam with 2 different levels of sedation scores
Phase 3

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single
Primary Purpose:
Prevention
Official Title:
Trial on The Efficacy of Sedation in Mechanically Ventilated Critically Ill Patients
Study Start Date :
Feb 1, 2003
Study Completion Date :
Jan 1, 2007

Outcome Measures

Primary Outcome Measures

  1. Post-traumatic stress disorders (PTSD) []

  2. Anxiety []

  3. Depression []

Secondary Outcome Measures

  1. Time to discharge from the Intensive Care Unit []

  2. Time to separation from mechanical ventilation []

  3. Rates of pulmonary and extra-pulmonary complications Hospital length of stay []

Eligibility Criteria

Criteria

Ages Eligible for Study:
16 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Critically ill patients requiring mechanical ventilation
Exclusion Criteria:
  • Neurological conditions or neuromuscular disease

  • Chronic renal failure, liver failure

  • Allergy to benzodiazepines or morphine

  • Drug overdose

  • Pregnancy

  • Non-cooperative

  • Treatment with HIV protease inhibitors or erythromycin

  • Refusal of consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 Geneva University Hospitals Geneva Switzerland 1211

Sponsors and Collaborators

  • University Hospital, Geneva
  • Swiss National Science Foundation

Investigators

  • Principal Investigator: Miriam M Treggiari, MD, University Hospital, Geneva

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00221520
Other Study ID Numbers:
  • 3200-068312
  • 2002DR2266
First Posted:
Sep 22, 2005
Last Update Posted:
Jan 11, 2007
Last Verified:
Jan 1, 2007
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 11, 2007